Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Global Epidemiology and Genetics of Hepatocellular Carcinoma
Ming Ren Toh, Evelyn Wong, Sunny H. Wong, et al.
Gastroenterology (2023) Vol. 164, Iss. 5, pp. 766-782
Closed Access | Times Cited: 263

Showing 1-25 of 263 citing articles:

Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy
Pan Song, Zirui Gao, Yige Bao, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 45
Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
Do Young Kim
Journal of Liver Cancer (2024) Vol. 24, Iss. 1, pp. 622-70
Open Access | Times Cited: 42
N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression
Xinyue Zhang, Tianhong Su, Yifan Wu, et al.
Cancer Research (2024) Vol. 84, Iss. 6, pp. 827-840
Closed Access | Times Cited: 30
Disulfidptosis-related lncRNA signatures assess immune microenvironment and drug sensitivity in hepatocellular carcinoma
Kequan Xu, Caixia Dai, Jialing Yang, et al.
Computers in Biology and Medicine (2024) Vol. 169, pp. 107930-107930
Closed Access | Times Cited: 17
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
Yau-Tuen Chan, Cheng Zhang, Junyu Wu, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17
A real-world drug safety surveillance study from the FAERS database of hepatocellular carcinoma patients receiving pembrolizumab alone and plus lenvatinib
Huaxiang Wang, Junjun Li, Xiuling Zhu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Mast cells: key players in digestive system tumors and their interactions with immune cells
Feihong Shu, Jie Yu, Youjia Liu, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Hepatocellular Carcinoma Screening: From Current Standard of Care to Future Directions
Michael Mohnasky, Sandra Gad, Andrew M. Moon, et al.
Journal of the American College of Radiology (2025) Vol. 22, Iss. 3, pp. 260-268
Closed Access | Times Cited: 1
Hepatocellular carcinoma
Cristina Dopazo, Kjetil Søreide, Elena Rangelova, et al.
European Journal of Surgical Oncology (2023) Vol. 50, Iss. 1, pp. 107313-107313
Closed Access | Times Cited: 25
PTTG1 Reprograms Asparagine Metabolism to Promote Hepatocellular Carcinoma Progression
Qi Zhou, Leijia Li, Feifei Sha, et al.
Cancer Research (2023) Vol. 83, Iss. 14, pp. 2372-2386
Open Access | Times Cited: 23
Small-molecule-based targeted therapy in liver cancer
Ming Yue, Yanqiu Gong, Xuewen Fu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 10, pp. 3260-3287
Closed Access | Times Cited: 9
PARD3 drives tumorigenesis through activating Sonic Hedgehog signalling in tumour-initiating cells in liver cancer
Junyu Wu, Hor‐Yue Tan, Yau-Tuen Chan, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 8
Comparison of the LiMAx test vs. the APRI+ALBI score for clinical utility in preoperative risk assessment in patients undergoing liver surgery – A European multicenter study
Jonas Santol, Markus Ammann, Tim Reese, et al.
European Journal of Surgical Oncology (2024) Vol. 50, Iss. 4, pp. 108048-108048
Closed Access | Times Cited: 8
Multiscale Structured Trimetal Oxide Heterojunctions for Urinary Metabolic Phenotype‐Dependent Screening of Early and Small Hepatocellular Carcinoma
Fangying Shi, Liuxin Ning, Nianrong Sun, et al.
Small Methods (2024)
Closed Access | Times Cited: 8
The IGF2BP2-lncRNA TRPC7-AS1 axis promotes hepatocellular carcinoma cell proliferation and invasion
Xu Zhang, Zilin Li, Huizong Nie, et al.
Cellular Signalling (2024) Vol. 117, pp. 111078-111078
Open Access | Times Cited: 7
Unlocking hepatocellular carcinoma aggression: STAMBPL1-mediated TRAF2 deubiquitination activates WNT/PI3K/NF-kb signaling pathway
Zhihuai Wang, Yinjie Zhang, Yuhang Shen, et al.
Biology Direct (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 7
Low-density lipoprotein cholesterol and risk of hepatocellular carcinoma: a Mendelian randomization and mediation analysis
Jiali Cao, Ziwen Wang, Mengpei Zhu, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 18
Predictive value of preoperative inflammatory indexes for postoperative early recurrence of hepatitis B-related hepatocellular carcinoma
Guo Wenpei, Yuan Li, Liangbo Li, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 16
Mechanism of metal ion-induced cell death in gastrointestinal cancer
Muhua Luan, Zhaotian Feng, Wenshuai Zhu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116574-116574
Open Access | Times Cited: 7
Da-Chai-Hu-Tang Formula inhibits the progression and metastasis in HepG2 cells through modulation of the PI3K/AKT/STAT3-induced cell cycle arrest and apoptosis
Zi-Wei Duan, Yong Liu, Peipei Zhang, et al.
Journal of Ethnopharmacology (2024) Vol. 331, pp. 118293-118293
Closed Access | Times Cited: 6
Qizhu anticancer prescription enhances immunosurveillance of liver cancer cells by regulating p21-dependent secretory phenotypes
Rui Hu, Jing Li, Qi Huang, et al.
Journal of Ethnopharmacology (2024) Vol. 333, pp. 118400-118400
Closed Access | Times Cited: 6
Liver function indicators and risk of hepatocellular carcinoma: a bidirectional mendelian randomization study
Shanshan Qin, Jing Wang, Haiqing Yuan, et al.
Frontiers in Genetics (2024) Vol. 14
Open Access | Times Cited: 5
A Grading System of Microvascular Invasion for Patients with Hepatocellular Carcinoma Undergoing Liver Resection with Curative Intent: A Multicenter Study
Han Wang, Junjie Chen, Shu‐Yi Yin, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 191-206
Open Access | Times Cited: 5
Clonorchis sinensis infection amplifies hepatocellular carcinoma stemness, predicting unfavorable prognosis
Qiumei Lin, Zeli Tang, Yuling Qin, et al.
PLoS neglected tropical diseases (2024) Vol. 18, Iss. 1, pp. e0011906-e0011906
Open Access | Times Cited: 5
Circ_0027791 contributes to the growth and immune evasion of hepatocellular carcinoma via the miR‐496/programmed cell death ligand 1 axis in an m6A‐dependent manner
Furong Yu, Peifei Fang, Yonghong Fang, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 6, pp. 3721-3733
Closed Access | Times Cited: 5
Page 1 - Next Page

Scroll to top